Algae-mediated bioremediation of ciprofloxacin through a symbiotic microalgae-bacteria consortium

The ciprofloxacin treating via microalga and its microalgae-bacteria consortium was investigated for discussing the potential application of microalgae-mediated bioremediation. As results, the maximum removal efficiency of ciprofloxacin by pure microalgae and the consortium was 87.5 ± 3.5 % (5 mg/L) and 96.1 ± 0.07 % (40 mg/L), respectively. The consortium enhanced the degradation rate to 0.81 d −1 compared with the pure microalgae (0.27 d −1 ). To reveal the symbiotic mechanism, extracellular polymeric substances , pigments contents, antioxidant enzymes and symbiotic bacterial community were analyzed. The malondialdehyde content in the pure microalgae (1622.6 ± 38.7 nmol/mg protein) was higher than that in the consortium (298.34 ± 2.4 nmol/mg protein), and there were obvious chlorophyll b accumulations (approximately 90 %) in consortium. In addition, the symbiotic bacteria had a positive effect on microalgal secretion of fulvic acid-type components. As mechanism, symbiotic bacteria improved ciprofloxacin biodegradation by reducing cell damage and secreting fulvic acid . The presence of Phycisphaeraceae and Rhizobiaceae , nitrogen fixation bacteria, in the consortium suggest that improvement of ciprofloxacin biodegradation might be associated with nitrogen co-metabolism as well. Collectively, this work elucidates the mechanism of enhancing elimination of ciprofloxacin via microalgae-bacteria consortium and accelerates development of microalgae-mediated aquaculture tailwater bioremediation.